References
Cong, L., & Zhang, F. (2015). Genome Engineering Using CRISPR-Cas9 System. Methods in Molecular Biology, 1239, 197-217.
Cribbs, A., & Perera, S. (2017). Science and Bioethics of CRISPR-Cas9 Gene Editing: An Analysis Towards Separating Facts and Fiction. YALE JOURNAL OF BIOLOGY AND MEDICINE, 90, 625-634.
Engineering T-Cells to Fight Cancer | Parker Institute for Cancer Immunotherapy. (2017). Retrieved from Parker Institute for Cancer Immunotherapy: https://www.parkerici.org/research_focus/best-in-class-t-cells/#progress
Friedlaender, G. E., Perry, C. R., Cierny, G., Muschler, G. F., Zych, G. A., Calhoun, J. A., . . . Yin, S. (2001). Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. The Journal of Bone and Joint Surgery, 83-A(Suppl 1(Pt 2)), 151-158.
Greenwald, A., Boden, S., Goldberg, V., Khan, Y., Laurencin, C., & Rosier, R. (2001). Bone-Graft Substitutes: Facts, Fictions, and Applications. THE JOURNAL OF BONE AND JOINT SURGERY, INCORPORATED, 83-A, 98-103.
International Osteoporosis Foundation. (2017). Retrieved from Facts and Statistics: https://www.iofbonehealth.org/facts-statistics
Kesselheim, A., & Avorn, J. (2016). Approving a Problematic Muscular Dystrophy Drug. JAMA.
Knothe Tate, M., Adamson, J., Tami, A., & Bauer, T. (2004). The osteocyte. The International Journal of Biochemistry & Cell Biology, 36, 1-8.
Kosicki, M., Tomberg, K., & Bradley, A. (2018). Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements. Nature Biotechnology, 1-8.
Lo, K.-H., Ashe, K., Kan, H., & Laurencin, C. (2012). The role of small molecules in musculoskeletal regeneration. Regen. Med, 7(4), 535-549.
Lu, C.-H., Chang, Y.-H., Lin, S.-Y., Li, K.-C., & Hu, Y.-C. (2013). Recent progresses in gene delivery-based bone tissue engineering. Biotechnology Advances, 31, 1695-1706.
Nauth, A., Ristevski, B., Li, R., & Schemitsch, E. (2011). Growth factors and bone regeneration: How much bone can we expect? Injury, 42, 574-579.
R.T. Franceschi. (2005). Biological Approaches to Bone Regeneration by Gene Therapy. Journal of Dental Research, 84(12), 1093-1103.
Reardon, S. (2016, 6 22). Nature. Nature News. doi:10.1038/nature.2016.20137
Roberts, T., & Rosenbaum, A. (2012). Bone grafts, bone substitutes and orthobiologics. Organogenesis, 8(4), 114-124.
Rosa, A. L. (2017). Research Supported by FAPESP. Gene therapy for bone regeneration using CRISPR-Cas9 system.
Southwood, L., Acvs, D., Frisbie, D., Kawcak, C., & Wayne Mcilwraith, C. (2004). Delivery of Growth Factors Using Gene Therapy to Enhance Bone Healing. Veterinary Surgery, 33, 565-578.
The Burden of the Musculoskeletal Diseases in the United States: Prevalence, Societal, and Economic Cost (3rd Edition). (2014). Retrieved from www.boneandjointburden.org
Vo, T., Kasper, F., & Mikos, A. (2012). Strategies for controlled delivery of growth factors and cells for bone regeneration ☆. Advanced Drug Delivery Reviews, 64, 1292-1309.
Comments: